Metformin in Colorectal Cancer: Molecular Mechanism, Preclinical and Clinical Aspects

Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/s13046-019-1495-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Molecular Pathways: Preclinical Models and Clinical Trials With Metformin in Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Metformin and Colorectal Cancer Risk—Letter

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2018English

Molecular Mechanism of LKB1 in the Invasion and Metastasis of Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

Diabetes, Metformin Use, and Colorectal Cancer Survival in Postmenopausal Women

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2013English

Is Metformin a Treatment Opportunity for Colorectal Cancer?

Journal of Evolution of Medical and Dental Sciences
2020English

Evaluating Patient-Derived Colorectal Cancer Xenografts as Preclinical Models by Comparison With Patient Clinical Data

Cancer Research
Cancer ResearchOncology
2015English

Molecular Classification and Correlates in Colorectal Cancer

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2008English

Immunotherapeutic Strategies in Breast Cancer: Preclinical and Clinical Trials

2007English

New Insight Into Metformin Mechanism of Action and Clinical Application

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy